MENU
GDOC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
GDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for GDOC with price predictions
Sep 11, 2026

GDOC in -2.04% downward trend, declining for three consecutive days on August 28, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GDOC declined for three days, in 192 of 233 cases, the price declined further within the following month. The odds of a continued downward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GDOC moved out of overbought territory on August 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 22 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GDOC as a result. In 58 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for GDOC turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 35 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

GDOC moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for GDOC entered a downward trend on August 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

GDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Exact Sciences Corp (NASDAQ:EXAS), Align Technology (NASDAQ:ALGN).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Goldman Sachs Future Health Care Eq ETF ETF is 86.48B. The market cap for tickers in the group ranges from 1.06B to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is MLTX at 1.06B.

High and low price notable news

The average weekly price growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was -3%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 10%. ROIV experienced the highest price growth at 17%, while COO experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was 29%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 56
Price Growth Rating: 47
SMR Rating: 61
Profit Risk Rating: 75
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
GDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
Goldman Sachs ETF Trust200 West StreetNew York
Phone
(212) 902-1000
Web
am.gs.com
GDOC in -2.04% downward trend, declining for three consecutive days on August 28, 2026